Literature DB >> 32818967

Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996-2018.

John O Otshudiema1,2, Anna M Acosta2, Pamela K Cassiday2, Stephen C Hadler3, Susan Hariri2, Tejpratap S P Tiwari2.   

Abstract

BACKGROUND: Respiratory diphtheria is a toxin-mediated disease caused by Corynebacterium diphtheriae. Diphtheria-like illness, clinically indistinguishable from diphtheria, is caused by Corynebacterium ulcerans, a zoonotic bacterium that can also produce diphtheria toxin. In the United States, respiratory diphtheria is nationally notifiable: specimens from suspected cases are submitted to the Centers for Disease Control and Prevention (CDC) for species and toxin confirmation, and diphtheria antitoxin (DAT) is obtained from CDC for treatment. We summarize the epidemiology of respiratory diphtheria and diphtheria-like illness and describe DAT use during 1996-2018 in the United States.
METHODS: We described respiratory diphtheria cases reported to the National Notifiable Diseases Surveillance System (NNDSS) and C. ulcerans-related diphtheria-like illness identified through specimen submissions to CDC during 1996-2018. We reviewed DAT requests from 1997 to 2018.
RESULTS: From 1996 to 2018, 14 respiratory diphtheria cases were reported to NNDSS. Among these 14 cases, 1 was toxigenic and 3 were nontoxigenic C. diphtheriae by culture and Elek, 6 were culture-negative but polymerase chain reaction (PCR)-positive for diphtheria toxin gene, 1 was culture-positive without further testing, and the remaining 3 were either not tested or tested negative. Five cases of respiratory diphtheria-like illness caused by toxigenic C. ulcerans were identified. DAT was requested by healthcare providers for 151 suspected diphtheria cases between 1997 and 2018, with an average of 11 requests per year from 1997 to 2007, and 3 per year from 2008 to 2018.
CONCLUSIONS: Respiratory diphtheria remains rare in the United States, and requests for DAT have declined. Incidental identification of C. ulcerans-related diphtheria-like illness suggests surveillance of this condition might be warranted. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  zzm321990 Corynebacterium diphtheriaezzm321990 ; zzm321990 Corynebacterium ulceranszzm321990 ; diphtheria; diphtheria-like illness; toxin-producing

Mesh:

Substances:

Year:  2021        PMID: 32818967      PMCID: PMC8876369          DOI: 10.1093/cid/ciaa1218

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Persistence of a distinct Corynebacterium diphtheriae clonal group within two communities in the United States and Canada where diphtheria is endemic.

Authors:  C K Marston; F Jamieson; F Cahoon; G Lesiak; A Golaz; M Reeves; T Popovic
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Respiratory diphtheria caused by Corynebacterium ulcerans--Terre Haute, Indiana, 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-04-18       Impact factor: 17.586

3.  Cutaneous and pharyngeal diphtheria imported from the Indian subcontinent.

Authors:  P E Hart; P Y Lee; D C Macallan; M H Wansbrough-Jones
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

4.  Diphtheria outbreak in Thailand, 2012; seroprevalence of diphtheria antibodies among Thai adults and its implications for immunization programs.

Authors:  Nasamon Wanlapakorn; Pornsak Yoocharoen; Piyanit Tharmaphornpilas; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2014-09       Impact factor: 0.267

5.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

Review 6.  Corynebacterium ulcerans, an emerging human pathogen.

Authors:  Elena Hacker; Camila A Antunes; Ana L Mattos-Guaraldi; Andreas Burkovski; Andreas Tauch
Journal:  Future Microbiol       Date:  2016-08-22       Impact factor: 3.165

7.  Detection of differences in the nucleotide and amino acid sequences of diphtheria toxin from Corynebacterium diphtheriae and Corynebacterium ulcerans causing extrapharyngeal infections.

Authors:  Andreas Sing; Michael Hogardt; Suse Bierschenk; Jürgen Heesemann
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

8.  Diphtheria outbreak in Yemen: the impact of conflict on a fragile health system.

Authors:  Fekri Dureab; Maysoon Al-Sakkaf; Osan Ismail; Naasegnibe Kuunibe; Johannes Krisam; Olaf Müller; Albrecht Jahn
Journal:  Confl Health       Date:  2019-05-22       Impact factor: 2.723

9.  Global Epidemiology of Diphtheria, 2000-20171.

Authors:  Kristie E N Clarke; Adam MacNeil; Stephen Hadler; Colleen Scott; Tejpratap S P Tiwari; Thomas Cherian
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

10.  Diphtheria outbreak in Lao People's Democratic Republic, 2012-2013.

Authors:  Carolyn Sein; Tejpratap Tiwari; Adam Macneil; Kathleen Wannemuehler; Chanthavy Soulaphy; Phouthone Souliphone; Rita Reyburn; Alejandro Ramirez Gonzalez; Margaret Watkins; James L Goodson
Journal:  Vaccine       Date:  2016-07-12       Impact factor: 3.641

View more
  3 in total

Review 1.  A Review of Adverse Events From the Use of Diphtheria Antitoxin (DAT) in the United States, 2004-2019.

Authors:  Valerie D Bampoe; Haley C Boswell; Yon C Yu; Anna M Acosta
Journal:  Clin Infect Dis       Date:  2022-06-10       Impact factor: 20.999

Review 2.  Exotoxin-Targeted Drug Modalities as Antibiotic Alternatives.

Authors:  Moona Sakari; Arttu Laisi; Arto T Pulliainen
Journal:  ACS Infect Dis       Date:  2022-01-31       Impact factor: 5.084

3.  Toxigenic Corynebacterium diphtheriae Infection in Cat, Texas, USA.

Authors:  Ronald Tyler; Layda Rincon; Michael R Weigand; Lingzi Xiaoli; Anna M Acosta; Daniel Kurien; Hong Ju; Sonia Lingsweiler; Emilie Yvonne Prot
Journal:  Emerg Infect Dis       Date:  2022-08       Impact factor: 16.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.